These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11050921)

  • 1. [Effects of radiotherapy and chemotherapy on lung function in patients with breast neoplasm and lymphoma: a follow-up study].
    Herrmann T
    Strahlenther Onkol; 2000 Sep; 176(9):437. PubMed ID: 11050921
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
    Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
    Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?
    Beal K; Hudis C; Norton L; Wagman R; McCormick B
    Breast J; 2005; 11(5):317-20. PubMed ID: 16174151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy.
    Minor GI; Yashar CM; Spanos WJ; Jose BO; Silverman CL; Carrascosa LA; Farmer M; Paris KJ
    Breast J; 2006; 12(1):48-52. PubMed ID: 16409586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
    Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
    Nieder C; Schill S; Kneschaurek P; Molls M
    Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Theodorou K; Rajala J; Pitkänen MA; Holli K; Ojala AT; Hyödynmaa S; Järvenpää R; Lind BK; Kappas C
    Phys Med Biol; 2006 Feb; 51(3):L1-9. PubMed ID: 16424572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late regional density changes of the lung after radiotherapy for breast cancer.
    Vågane R; Danielsen T; Fosså SD; Løkkevik E; Olsen DR
    Radiother Oncol; 2009 Jan; 90(1):148-52. PubMed ID: 18262670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
    De Giorgi U; Giannini M; Frassineti L; Kopf B; Palazzi S; Giovannini N; Zumaglini F; Rosti G; Emiliani E; Marangolo M
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1165-9. PubMed ID: 16682141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
    Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concurrent chemoradiotherapy for advanced breast cancer].
    Karasawa K; Ito K; Hirowatari H; Saito AI; Izawa H
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():402-6. PubMed ID: 17682184
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary function testing in women with breast cancer treated with radiotherapy and chemotherapy.
    Spyropoulou D; Leotsinidis M; Tsiamita M; Spiropoulos K; Kardamakis D
    In Vivo; 2009; 23(5):867-71. PubMed ID: 19779125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation.
    Teh AY; Park EJ; Shen L; Chung HT
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1309-15. PubMed ID: 19427749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma.
    Theuws JC; Kwa SL; Wagenaar AC; Seppenwoolde Y; Boersma LJ; Damen EM; Muller SH; Baas P; Lebesque JV
    Radiother Oncol; 1998 Dec; 49(3):233-43. PubMed ID: 10075256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.
    Siracusano L; Balzarotti M; Magagnoli M; Castagna L; Rahal D; Santoro A
    Am J Hematol; 2005 Apr; 78(4):312-3. PubMed ID: 15795908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: chronic myelopathy after combined chemo-radiotherapy in a patient with relapsed mediastinal B-cell lymphoma.
    Dormann S; Duffner U; Martini C; Böhm N; Korinthenberg R; Niemeyer C
    Med Pediatr Oncol; 2002 Jun; 38(6):442-4. PubMed ID: 11984808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.